TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))
| NOVA PHARMA SOLUTIONS BERHAD |
| Type | Announcement |
| Subject | TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A)) |
| Description | NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY")
UNCONDITIONAL MANDATORY TAKE-OVER OFFER FROM KENANGA INVESTMENT BANK BERHAD ("KENANGA IB") ON BEHALF OF SOUTHERN SCORE BUILDERS BERHAD ("SSBB" OR "THE OFFEROR") TO ACQUIRE ALL THE REMAINING ORDINARY SHARES IN NPS NOT ALREADY HELD BY THE OFFEROR AND THE PERSONS ACTING IN CONCERT WITH IT ("OFFER SHARE(S)") FOR A CASH CONSIDERATION OF RM0.37 PER OFFER SHARE ("OFFER") |
|
Reference is made to NPS’ announcements dated 22 December 2025, 23 December 2025, 29 December 2025, 12 January 2026, 22 January 2026, 23 January 2026 and 29 January 2026 (“Announcements”). Unless otherwise stated, all abbreviations used herein shall have the same meaning as defined in the Announcements.
We wish to announce that the Company had on 3 February 2026, received a press notice from Kenanga IB, on behalf of the Offeror, informing that the Offeror has received Valid Acceptance of not less than nine-tenths in the nominal value of the Offer Shares (excluding NPS Shares already held by the Offeror and its PACs as at the date of the Offer).
Accordingly, the Offeror will invoke the provisions of subsection 222(1) of the CMSA to compulsorily acquire any outstanding Offer Shares from the Dissenting Shareholders and issue a compulsory acquisition notice in the form or manner specified by the SC under subsection 222(1) of the CMSA to all Dissenting Shareholders within 2 months from 3 February 2026.
The Offer will remain open for acceptances until 5:00 p.m. (Malaysian time) on Friday, 27 February 2026.
This announcement is dated 3 February 2026. |
|
Please refer attachment below.
Announcement Info
| Company Name | NOVA PHARMA SOLUTIONS BERHAD |
| Stock Name | NPS |
| Date Announced | 03 Feb 2026 |
| Category | General Announcement for PLC |
| Reference Number | GA1-29012026-00088 |